ALNYLAM PHARMACEUTICALS INC's ticker is and the CUSIP is 02043Q907. A total of 6 filers reported holding ALNYLAM PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $85,025,700 | +253.4% | 349,900 | +117.3% | 0.02% | +280.0% |
| Q1 2024 | $24,061,450 | +166.9% | 161,000 | +241.8% | 0.01% | +150.0% |
| Q4 2023 | $9,015,411 | +30.2% | 47,100 | +20.5% | 0.00% | 0.0% |
| Q3 2023 | $6,924,610 | +58.5% | 39,100 | +70.0% | 0.00% | +100.0% |
| Q2 2023 | $4,368,620 | -42.5% | 23,000 | -39.3% | 0.00% | -66.7% |
| Q1 2023 | $7,592,128 | -53.7% | 37,900 | -45.1% | 0.00% | -62.5% |
| Q4 2022 | $16,397,850 | +17.5% | 69,000 | -1.0% | 0.01% | +33.3% |
| Q3 2022 | $13,951,000 | -55.1% | 69,700 | -67.3% | 0.01% | -53.8% |
| Q2 2022 | $31,095,000 | – | 213,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 41,300 | $8,273,216 | 0.03% |
| SIMPLEX TRADING, LLC | 36,800 | $7,371 | 0.01% |
| JANE STREET GROUP, LLC | 37,900 | $7,592,128 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| JPMORGAN CHASE & CO | 7,500 | $1,502,000 | 0.00% |